nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Gastrointestinal disorder—Vincristine—kidney cancer	0.000463	0.000463	CcSEcCtD
Cefpodoxime—Fatigue—Vincristine—kidney cancer	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Rash—Erlotinib—kidney cancer	0.000461	0.000461	CcSEcCtD
Cefpodoxime—Dermatitis—Erlotinib—kidney cancer	0.000461	0.000461	CcSEcCtD
Cefpodoxime—Palpitations—Paclitaxel—kidney cancer	0.000461	0.000461	CcSEcCtD
Cefpodoxime—Hyponatraemia—Doxorubicin—kidney cancer	0.00046	0.00046	CcSEcCtD
Cefpodoxime—Insomnia—Gemcitabine—kidney cancer	0.00046	0.00046	CcSEcCtD
Cefpodoxime—Headache—Erlotinib—kidney cancer	0.000458	0.000458	CcSEcCtD
Cefpodoxime—Tinnitus—Capecitabine—kidney cancer	0.000458	0.000458	CcSEcCtD
Cefpodoxime—Loss of consciousness—Paclitaxel—kidney cancer	0.000458	0.000458	CcSEcCtD
Cefpodoxime—Pain—Vincristine—kidney cancer	0.000458	0.000458	CcSEcCtD
Cefpodoxime—Constipation—Vincristine—kidney cancer	0.000458	0.000458	CcSEcCtD
Cefpodoxime—Paraesthesia—Gemcitabine—kidney cancer	0.000456	0.000456	CcSEcCtD
Cefpodoxime—Cough—Paclitaxel—kidney cancer	0.000455	0.000455	CcSEcCtD
Cefpodoxime—Asthenia—Sunitinib—kidney cancer	0.000455	0.000455	CcSEcCtD
Cefpodoxime—Dyspnoea—Gemcitabine—kidney cancer	0.000453	0.000453	CcSEcCtD
Cefpodoxime—Nausea—Vinblastine—kidney cancer	0.000452	0.000452	CcSEcCtD
Cefpodoxime—Somnolence—Gemcitabine—kidney cancer	0.000452	0.000452	CcSEcCtD
Cefpodoxime—Convulsion—Paclitaxel—kidney cancer	0.000452	0.000452	CcSEcCtD
Cefpodoxime—Migraine—Doxorubicin—kidney cancer	0.000451	0.000451	CcSEcCtD
Cefpodoxime—Nausea—Everolimus—kidney cancer	0.000451	0.000451	CcSEcCtD
Cefpodoxime—Diarrhoea—Sorafenib—kidney cancer	0.00045	0.00045	CcSEcCtD
Cefpodoxime—Hypertension—Paclitaxel—kidney cancer	0.00045	0.00045	CcSEcCtD
Cefpodoxime—Pruritus—Sunitinib—kidney cancer	0.000448	0.000448	CcSEcCtD
Cefpodoxime—Myalgia—Paclitaxel—kidney cancer	0.000444	0.000444	CcSEcCtD
Cefpodoxime—Chest pain—Paclitaxel—kidney cancer	0.000444	0.000444	CcSEcCtD
Cefpodoxime—Anxiety—Paclitaxel—kidney cancer	0.000442	0.000442	CcSEcCtD
Cefpodoxime—Face oedema—Doxorubicin—kidney cancer	0.000442	0.000442	CcSEcCtD
Cefpodoxime—Decreased appetite—Gemcitabine—kidney cancer	0.000442	0.000442	CcSEcCtD
Cefpodoxime—Hypersensitivity—Dactinomycin—kidney cancer	0.000442	0.000442	CcSEcCtD
Cefpodoxime—Chills—Capecitabine—kidney cancer	0.000441	0.000441	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000439	0.000439	CcSEcCtD
Cefpodoxime—Discomfort—Paclitaxel—kidney cancer	0.000439	0.000439	CcSEcCtD
Cefpodoxime—Fatigue—Gemcitabine—kidney cancer	0.000438	0.000438	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Vincristine—kidney cancer	0.000438	0.000438	CcSEcCtD
Cefpodoxime—Dizziness—Sorafenib—kidney cancer	0.000435	0.000435	CcSEcCtD
Cefpodoxime—Pain—Gemcitabine—kidney cancer	0.000435	0.000435	CcSEcCtD
Cefpodoxime—Constipation—Gemcitabine—kidney cancer	0.000435	0.000435	CcSEcCtD
Cefpodoxime—Nausea—Erlotinib—kidney cancer	0.000435	0.000435	CcSEcCtD
Cefpodoxime—Alopecia—Capecitabine—kidney cancer	0.000434	0.000434	CcSEcCtD
Cefpodoxime—Dry mouth—Paclitaxel—kidney cancer	0.000434	0.000434	CcSEcCtD
Cefpodoxime—Diarrhoea—Sunitinib—kidney cancer	0.000433	0.000433	CcSEcCtD
Cefpodoxime—Asthenia—Dactinomycin—kidney cancer	0.00043	0.00043	CcSEcCtD
Cefpodoxime—Confusional state—Paclitaxel—kidney cancer	0.000429	0.000429	CcSEcCtD
Cefpodoxime—Dehydration—Doxorubicin—kidney cancer	0.000426	0.000426	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Paclitaxel—kidney cancer	0.000426	0.000426	CcSEcCtD
Cefpodoxime—Abdominal pain—Vincristine—kidney cancer	0.000424	0.000424	CcSEcCtD
Cefpodoxime—Body temperature increased—Vincristine—kidney cancer	0.000424	0.000424	CcSEcCtD
Cefpodoxime—Flatulence—Capecitabine—kidney cancer	0.000422	0.000422	CcSEcCtD
Cefpodoxime—Dry skin—Doxorubicin—kidney cancer	0.00042	0.00042	CcSEcCtD
Cefpodoxime—Dysgeusia—Capecitabine—kidney cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Dizziness—Sunitinib—kidney cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Feeling abnormal—Gemcitabine—kidney cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Shock—Paclitaxel—kidney cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Vomiting—Sorafenib—kidney cancer	0.000419	0.000419	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Paclitaxel—kidney cancer	0.000417	0.000417	CcSEcCtD
Cefpodoxime—Rash—Sorafenib—kidney cancer	0.000415	0.000415	CcSEcCtD
Cefpodoxime—Dermatitis—Sorafenib—kidney cancer	0.000415	0.000415	CcSEcCtD
Cefpodoxime—Back pain—Capecitabine—kidney cancer	0.000414	0.000414	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000412	0.000412	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000412	0.000412	CcSEcCtD
Cefpodoxime—Headache—Sorafenib—kidney cancer	0.000412	0.000412	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Paclitaxel—kidney cancer	0.000411	0.000411	CcSEcCtD
Cefpodoxime—Diarrhoea—Dactinomycin—kidney cancer	0.00041	0.00041	CcSEcCtD
Cefpodoxime—Anorexia—Paclitaxel—kidney cancer	0.000406	0.000406	CcSEcCtD
Cefpodoxime—Gastritis—Doxorubicin—kidney cancer	0.000405	0.000405	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000404	0.000404	CcSEcCtD
Cefpodoxime—Vomiting—Sunitinib—kidney cancer	0.000403	0.000403	CcSEcCtD
Cefpodoxime—Body temperature increased—Gemcitabine—kidney cancer	0.000402	0.000402	CcSEcCtD
Cefpodoxime—Tremor—Capecitabine—kidney cancer	0.000401	0.000401	CcSEcCtD
Cefpodoxime—Rash—Sunitinib—kidney cancer	0.000399	0.000399	CcSEcCtD
Cefpodoxime—Dermatitis—Sunitinib—kidney cancer	0.000399	0.000399	CcSEcCtD
Cefpodoxime—Abdominal distension—Doxorubicin—kidney cancer	0.000399	0.000399	CcSEcCtD
Cefpodoxime—Hypotension—Paclitaxel—kidney cancer	0.000398	0.000398	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Capecitabine—kidney cancer	0.000397	0.000397	CcSEcCtD
Cefpodoxime—Headache—Sunitinib—kidney cancer	0.000397	0.000397	CcSEcCtD
Cefpodoxime—Asthma—Doxorubicin—kidney cancer	0.000396	0.000396	CcSEcCtD
Cefpodoxime—Anaemia—Capecitabine—kidney cancer	0.000396	0.000396	CcSEcCtD
Cefpodoxime—Hypersensitivity—Vincristine—kidney cancer	0.000395	0.000395	CcSEcCtD
Cefpodoxime—Eosinophilia—Doxorubicin—kidney cancer	0.000392	0.000392	CcSEcCtD
Cefpodoxime—Nausea—Sorafenib—kidney cancer	0.000391	0.000391	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000388	0.000388	CcSEcCtD
Cefpodoxime—Malaise—Capecitabine—kidney cancer	0.000386	0.000386	CcSEcCtD
Cefpodoxime—Insomnia—Paclitaxel—kidney cancer	0.000385	0.000385	CcSEcCtD
Cefpodoxime—Vertigo—Capecitabine—kidney cancer	0.000384	0.000384	CcSEcCtD
Cefpodoxime—Asthenia—Vincristine—kidney cancer	0.000384	0.000384	CcSEcCtD
Cefpodoxime—Syncope—Capecitabine—kidney cancer	0.000384	0.000384	CcSEcCtD
Cefpodoxime—Leukopenia—Capecitabine—kidney cancer	0.000383	0.000383	CcSEcCtD
Cefpodoxime—Paraesthesia—Paclitaxel—kidney cancer	0.000382	0.000382	CcSEcCtD
Cefpodoxime—Vomiting—Dactinomycin—kidney cancer	0.000381	0.000381	CcSEcCtD
Cefpodoxime—Bronchitis—Doxorubicin—kidney cancer	0.000381	0.000381	CcSEcCtD
Cefpodoxime—Dyspnoea—Paclitaxel—kidney cancer	0.000379	0.000379	CcSEcCtD
Cefpodoxime—Somnolence—Paclitaxel—kidney cancer	0.000378	0.000378	CcSEcCtD
Cefpodoxime—Palpitations—Capecitabine—kidney cancer	0.000378	0.000378	CcSEcCtD
Cefpodoxime—Rash—Dactinomycin—kidney cancer	0.000378	0.000378	CcSEcCtD
Cefpodoxime—Nausea—Sunitinib—kidney cancer	0.000376	0.000376	CcSEcCtD
Cefpodoxime—Loss of consciousness—Capecitabine—kidney cancer	0.000376	0.000376	CcSEcCtD
Cefpodoxime—Pancytopenia—Doxorubicin—kidney cancer	0.000376	0.000376	CcSEcCtD
Cefpodoxime—Dyspepsia—Paclitaxel—kidney cancer	0.000375	0.000375	CcSEcCtD
Cefpodoxime—Cough—Capecitabine—kidney cancer	0.000373	0.000373	CcSEcCtD
Cefpodoxime—Dysuria—Doxorubicin—kidney cancer	0.00037	0.00037	CcSEcCtD
Cefpodoxime—Neutropenia—Doxorubicin—kidney cancer	0.00037	0.00037	CcSEcCtD
Cefpodoxime—Decreased appetite—Paclitaxel—kidney cancer	0.00037	0.00037	CcSEcCtD
Cefpodoxime—Hypertension—Capecitabine—kidney cancer	0.000369	0.000369	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000367	0.000367	CcSEcCtD
Cefpodoxime—Fatigue—Paclitaxel—kidney cancer	0.000367	0.000367	CcSEcCtD
Cefpodoxime—Diarrhoea—Vincristine—kidney cancer	0.000367	0.000367	CcSEcCtD
Cefpodoxime—Pollakiuria—Doxorubicin—kidney cancer	0.000366	0.000366	CcSEcCtD
Cefpodoxime—Asthenia—Gemcitabine—kidney cancer	0.000365	0.000365	CcSEcCtD
Cefpodoxime—Chest pain—Capecitabine—kidney cancer	0.000364	0.000364	CcSEcCtD
Cefpodoxime—Myalgia—Capecitabine—kidney cancer	0.000364	0.000364	CcSEcCtD
Cefpodoxime—Constipation—Paclitaxel—kidney cancer	0.000364	0.000364	CcSEcCtD
Cefpodoxime—Pain—Paclitaxel—kidney cancer	0.000364	0.000364	CcSEcCtD
Cefpodoxime—Anxiety—Capecitabine—kidney cancer	0.000363	0.000363	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000361	0.000361	CcSEcCtD
Cefpodoxime—Weight increased—Doxorubicin—kidney cancer	0.00036	0.00036	CcSEcCtD
Cefpodoxime—Discomfort—Capecitabine—kidney cancer	0.00036	0.00036	CcSEcCtD
Cefpodoxime—Pruritus—Gemcitabine—kidney cancer	0.00036	0.00036	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Doxorubicin—kidney cancer	0.000357	0.000357	CcSEcCtD
Cefpodoxime—Dry mouth—Capecitabine—kidney cancer	0.000356	0.000356	CcSEcCtD
Cefpodoxime—Nausea—Dactinomycin—kidney cancer	0.000356	0.000356	CcSEcCtD
Cefpodoxime—Pneumonia—Doxorubicin—kidney cancer	0.000355	0.000355	CcSEcCtD
Cefpodoxime—Dizziness—Vincristine—kidney cancer	0.000354	0.000354	CcSEcCtD
Cefpodoxime—Confusional state—Capecitabine—kidney cancer	0.000352	0.000352	CcSEcCtD
Cefpodoxime—Feeling abnormal—Paclitaxel—kidney cancer	0.000351	0.000351	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00035	0.00035	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000348	0.000348	CcSEcCtD
Cefpodoxime—Diarrhoea—Gemcitabine—kidney cancer	0.000348	0.000348	CcSEcCtD
Cefpodoxime—Renal failure—Doxorubicin—kidney cancer	0.000347	0.000347	CcSEcCtD
Cefpodoxime—Stomatitis—Doxorubicin—kidney cancer	0.000344	0.000344	CcSEcCtD
Cefpodoxime—Shock—Capecitabine—kidney cancer	0.000344	0.000344	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Capecitabine—kidney cancer	0.000342	0.000342	CcSEcCtD
Cefpodoxime—Vomiting—Vincristine—kidney cancer	0.000341	0.000341	CcSEcCtD
Cefpodoxime—Urticaria—Paclitaxel—kidney cancer	0.000338	0.000338	CcSEcCtD
Cefpodoxime—Rash—Vincristine—kidney cancer	0.000338	0.000338	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Capecitabine—kidney cancer	0.000338	0.000338	CcSEcCtD
Cefpodoxime—Dermatitis—Vincristine—kidney cancer	0.000338	0.000338	CcSEcCtD
Cefpodoxime—Haematuria—Doxorubicin—kidney cancer	0.000337	0.000337	CcSEcCtD
Cefpodoxime—Body temperature increased—Paclitaxel—kidney cancer	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Abdominal pain—Paclitaxel—kidney cancer	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Headache—Vincristine—kidney cancer	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Epistaxis—Doxorubicin—kidney cancer	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Anorexia—Capecitabine—kidney cancer	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—kidney cancer	0.000331	0.000331	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—kidney cancer	0.000329	0.000329	CcSEcCtD
Cefpodoxime—Hypotension—Capecitabine—kidney cancer	0.000326	0.000326	CcSEcCtD
Cefpodoxime—Vomiting—Gemcitabine—kidney cancer	0.000323	0.000323	CcSEcCtD
Cefpodoxime—Rash—Gemcitabine—kidney cancer	0.000321	0.000321	CcSEcCtD
Cefpodoxime—Dermatitis—Gemcitabine—kidney cancer	0.00032	0.00032	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—kidney cancer	0.000319	0.000319	CcSEcCtD
Cefpodoxime—Headache—Gemcitabine—kidney cancer	0.000318	0.000318	CcSEcCtD
Cefpodoxime—Nausea—Vincristine—kidney cancer	0.000318	0.000318	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000318	0.000318	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—kidney cancer	0.000318	0.000318	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—kidney cancer	0.000317	0.000317	CcSEcCtD
Cefpodoxime—Insomnia—Capecitabine—kidney cancer	0.000316	0.000316	CcSEcCtD
Cefpodoxime—Paraesthesia—Capecitabine—kidney cancer	0.000314	0.000314	CcSEcCtD
Cefpodoxime—Hypersensitivity—Paclitaxel—kidney cancer	0.000314	0.000314	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—kidney cancer	0.000312	0.000312	CcSEcCtD
Cefpodoxime—Dyspnoea—Capecitabine—kidney cancer	0.000311	0.000311	CcSEcCtD
Cefpodoxime—Dyspepsia—Capecitabine—kidney cancer	0.000307	0.000307	CcSEcCtD
Cefpodoxime—Asthenia—Paclitaxel—kidney cancer	0.000305	0.000305	CcSEcCtD
Cefpodoxime—Decreased appetite—Capecitabine—kidney cancer	0.000304	0.000304	CcSEcCtD
Cefpodoxime—Nausea—Gemcitabine—kidney cancer	0.000302	0.000302	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000302	0.000302	CcSEcCtD
Cefpodoxime—Fatigue—Capecitabine—kidney cancer	0.000301	0.000301	CcSEcCtD
Cefpodoxime—Pruritus—Paclitaxel—kidney cancer	0.000301	0.000301	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—kidney cancer	0.0003	0.0003	CcSEcCtD
Cefpodoxime—Constipation—Capecitabine—kidney cancer	0.000299	0.000299	CcSEcCtD
Cefpodoxime—Pain—Capecitabine—kidney cancer	0.000299	0.000299	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—kidney cancer	0.000295	0.000295	CcSEcCtD
Cefpodoxime—Diarrhoea—Paclitaxel—kidney cancer	0.000291	0.000291	CcSEcCtD
Cefpodoxime—Feeling abnormal—Capecitabine—kidney cancer	0.000288	0.000288	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Capecitabine—kidney cancer	0.000286	0.000286	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—kidney cancer	0.000284	0.000284	CcSEcCtD
Cefpodoxime—Dizziness—Paclitaxel—kidney cancer	0.000281	0.000281	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—kidney cancer	0.00028	0.00028	CcSEcCtD
Cefpodoxime—Urticaria—Capecitabine—kidney cancer	0.000277	0.000277	CcSEcCtD
Cefpodoxime—Body temperature increased—Capecitabine—kidney cancer	0.000276	0.000276	CcSEcCtD
Cefpodoxime—Abdominal pain—Capecitabine—kidney cancer	0.000276	0.000276	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—kidney cancer	0.000272	0.000272	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—kidney cancer	0.000271	0.000271	CcSEcCtD
Cefpodoxime—Vomiting—Paclitaxel—kidney cancer	0.000271	0.000271	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—kidney cancer	0.00027	0.00027	CcSEcCtD
Cefpodoxime—Rash—Paclitaxel—kidney cancer	0.000268	0.000268	CcSEcCtD
Cefpodoxime—Dermatitis—Paclitaxel—kidney cancer	0.000268	0.000268	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—kidney cancer	0.000268	0.000268	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—kidney cancer	0.000267	0.000267	CcSEcCtD
Cefpodoxime—Headache—Paclitaxel—kidney cancer	0.000267	0.000267	CcSEcCtD
Cefpodoxime—Hypersensitivity—Capecitabine—kidney cancer	0.000257	0.000257	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—kidney cancer	0.000256	0.000256	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—kidney cancer	0.000255	0.000255	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—kidney cancer	0.000254	0.000254	CcSEcCtD
Cefpodoxime—Nausea—Paclitaxel—kidney cancer	0.000253	0.000253	CcSEcCtD
Cefpodoxime—Asthenia—Capecitabine—kidney cancer	0.000251	0.000251	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—kidney cancer	0.000249	0.000249	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—kidney cancer	0.000248	0.000248	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—kidney cancer	0.000247	0.000247	CcSEcCtD
Cefpodoxime—Pruritus—Capecitabine—kidney cancer	0.000247	0.000247	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—kidney cancer	0.000247	0.000247	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—kidney cancer	0.000244	0.000244	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—kidney cancer	0.000242	0.000242	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—kidney cancer	0.000241	0.000241	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—kidney cancer	0.000239	0.000239	CcSEcCtD
Cefpodoxime—Diarrhoea—Capecitabine—kidney cancer	0.000239	0.000239	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—kidney cancer	0.000238	0.000238	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—kidney cancer	0.000235	0.000235	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—kidney cancer	0.000235	0.000235	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—kidney cancer	0.000234	0.000234	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—kidney cancer	0.000232	0.000232	CcSEcCtD
Cefpodoxime—Dizziness—Capecitabine—kidney cancer	0.000231	0.000231	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—kidney cancer	0.00023	0.00023	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—kidney cancer	0.000227	0.000227	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—kidney cancer	0.000225	0.000225	CcSEcCtD
Cefpodoxime—Vomiting—Capecitabine—kidney cancer	0.000222	0.000222	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—kidney cancer	0.000222	0.000222	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—kidney cancer	0.00022	0.00022	CcSEcCtD
Cefpodoxime—Rash—Capecitabine—kidney cancer	0.00022	0.00022	CcSEcCtD
Cefpodoxime—Dermatitis—Capecitabine—kidney cancer	0.00022	0.00022	CcSEcCtD
Cefpodoxime—Headache—Capecitabine—kidney cancer	0.000219	0.000219	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—kidney cancer	0.000218	0.000218	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—kidney cancer	0.000215	0.000215	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—kidney cancer	0.00021	0.00021	CcSEcCtD
Cefpodoxime—Nausea—Capecitabine—kidney cancer	0.000207	0.000207	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000205	0.000205	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—kidney cancer	0.000204	0.000204	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—kidney cancer	0.000202	0.000202	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—kidney cancer	0.000201	0.000201	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—kidney cancer	0.0002	0.0002	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—kidney cancer	0.000198	0.000198	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—kidney cancer	0.000196	0.000196	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000194	0.000194	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—kidney cancer	0.000194	0.000194	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—kidney cancer	0.000193	0.000193	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—kidney cancer	0.000193	0.000193	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—kidney cancer	0.000186	0.000186	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000184	0.000184	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—kidney cancer	0.000179	0.000179	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—kidney cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—kidney cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—kidney cancer	0.000166	0.000166	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—kidney cancer	0.000162	0.000162	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—kidney cancer	0.000159	0.000159	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—kidney cancer	0.000154	0.000154	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—kidney cancer	0.000149	0.000149	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—kidney cancer	0.000143	0.000143	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—kidney cancer	0.000142	0.000142	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—kidney cancer	0.000142	0.000142	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—kidney cancer	0.000141	0.000141	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—kidney cancer	0.000134	0.000134	CcSEcCtD
